- Recommendation ID
- NG191/5
- Question
Is high-flow nasal oxygen effective in reducing breathlessness compared with standard care or conventional oxygen therapy for people in hospital with COVID-19 and respiratory failure when it is agreed that treatment will not be escalated beyond non-invasive respiratory support or palliative care is needed?
- Any explanatory notes
(if applicable) Suggested PICO (Population, Intervention, Comparator, Outcome)
P: adults over 18 years with COVID-19 having treatment for respiratory failure
I: high-flow nasal oxygen
C:
• standard care
• conventional oxygen therapy
O:
• patient experience
• symptom improvement
• frequency of coughing
• assessment of breathing pattern disorder
• impact of breathlessness on activities of daily living such as eating, drinking and movement
• recovery of sense of smell
• practicalities of maintaining high-flow nasal oxygen at home for patients who wish their end of life care to occur at home.
Source guidance details
- Comes from guidance
- COVID-19 rapid guideline: managing COVID-19
- Number
- NG191
- Date issued
- March 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 30/09/2021 |